New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

被引:0
作者
Sherif Mehralivand
Christian Thomas
Martin Puhr
Frank Claessens
Arjanneke F. van de Merbel
Anna Dubrovska
Guido Jenster
Christof Bernemann
Ulrich Sommer
Holger H. H. Erb
机构
[1] University Hospital Carl Gustav Carus,Department of Urology, Faculty of Medicine
[2] Technische Universität Dresden,Department of Urology
[3] Medical University of Innsbruck,Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine
[4] KU Leuven,Department of Urology
[5] Leiden University Medical Center,OncoRay
[6] Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf,National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus
[7] Helmholtz-Zentrum Dresden-Rossendorf,Institute of Radiooncology
[8] National Center for Tumor Diseases (NCT),OncoRay
[9] German Cancer Research Center (DKFZ),Faculty of Medicine
[10] University Hospital Carl Gustav Carus,German Cancer Consortium (DKTK)
[11] Technische Universität Dresden,Department of Urology, Erasmus MC Cancer Institute
[12] Helmholtz-Zentrum Dresden-Rossendorf (HZDR),Department of Urology
[13] Partner Site Dresden and German Cancer Research Center (DKFZ),Institut für Pathologie, Medical Faculty
[14] University Medical Center,undefined
[15] University Hospital Muenster,undefined
[16] University Hospital Carl Gustav Carus,undefined
[17] Technische Universität Dresden,undefined
来源
Journal of Translational Medicine | / 22卷
关键词
Androgen receptor; PCa; NR3C4; Androgen deprivation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
The androgen receptor (AR) is a crucial player in various aspects of male reproduction and has been associated with the development and progression of prostate cancer (PCa). Therefore, the protein is the linchpin of current PCa therapies. Despite great research efforts, the AR signaling pathway has still not been deciphered, and the emergence of resistance is still the biggest problem in PCa treatment. To discuss the latest developments in AR research, the “1st International Androgen Receptor Symposium” offered a forum for the exchange of clinical and scientific innovations around the role of the AR in prostate cancer (PCa) and to stimulate new collaborative interactions among leading scientists from basic, translational, and clinical research. The symposium included three sessions covering preclinical studies, prognostic and diagnostic biomarkers, and ongoing prostate cancer clinical trials. In addition, a panel discussion about the future direction of androgen deprivation therapy and anti-AR therapy in PCa was conducted. Therefore, the newest insights and developments in therapeutic strategies and biomarkers are discussed in this report.
引用
收藏
相关论文
共 414 条
[1]  
Quarmby VE(1990)Expression of recombinant androgen receptor in cultured mammalian cells Mol Endocrinol 4 1399-1407
[2]  
Kemppainen JA(1991)Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization Mol Endocrinol 5 1396-1404
[3]  
Sar M(1988)Cloning of human androgen receptor complementary DNA and localization to the X chromosome Science 240 327-330
[4]  
Lubahn DB(1997)The CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proc Natl Acad Sci USA 94 3320-3323
[5]  
French FS(2015)Androgen receptor: structure, role in prostate cancer and drug discovery Acta Pharmacol Sin 36 3-23
[6]  
Wilson EM(1995)The nuclear receptor superfamily: the second decade Cell 83 835-839
[7]  
Jenster G(1999)Regulation of androgen action Vitam Horm 55 309-352
[8]  
van der Korput HA(1991)Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression FASEB J 5 2243-2249
[9]  
van Vroonhoven C(2006)International union of pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors Pharmacol Rev 58 782-797
[10]  
van der Kwast TH(2014)Human androgen deficiency: insights gained from androgen receptor knockout mouse models Asian J Androl 16 169-177